Several other analysts have also recently commented on the company. Craig Hallum set a $20.00 target price on Trupanion and gave the company a hold rating in a report on Friday, October 11th. Zacks Investment Research cut Trupanion from a hold rating to a strong sell rating in a report on Sunday, November 3rd. TheStreet cut Trupanion from a c rating to a d+ rating in a report on Tuesday, July 30th. Northland Securities reiterated a buy rating and issued a $40.00 target price on shares of Trupanion in a report on Wednesday, November 6th. Finally, Royal Bank of Canada set a $38.00 price target on Trupanion and gave the company a buy rating in a research note on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company’s stock. The stock presently has a consensus rating of Hold and an average target price of $34.60.
NASDAQ TRUP traded up $1.28 during trading on Friday, hitting $32.35. 306,000 shares of the company’s stock were exchanged, compared to its average volume of 327,954. The stock’s 50 day moving average price is $24.47 and its two-hundred day moving average price is $29.23. Trupanion has a fifty-two week low of $20.84 and a fifty-two week high of $37.13. The company has a market cap of $1.09 billion, a PE ratio of -1,078.33 and a beta of 1.50. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.17.
In other Trupanion news, Director Robin A. Ferracone purchased 10,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were purchased at an average cost of $31.50 per share, with a total value of $315,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $24.62, for a total value of $98,480.00. Following the completion of the transaction, the insider now directly owns 1,465,759 shares in the company, valued at $36,086,986.58. The disclosure for this sale can be found here. Over the last three months, insiders sold 25,300 shares of company stock worth $634,486. Insiders own 13.61% of the company’s stock.
A number of institutional investors and hedge funds have recently modified their holdings of the business. DAVENPORT & Co LLC raised its position in shares of Trupanion by 14.4% during the second quarter. DAVENPORT & Co LLC now owns 258,771 shares of the financial services provider’s stock worth $9,349,000 after purchasing an additional 32,550 shares during the period. SG Americas Securities LLC acquired a new position in shares of Trupanion during the second quarter worth approximately $288,000. Aperio Group LLC acquired a new position in shares of Trupanion during the second quarter worth approximately $166,000. Public Employees Retirement Association of Colorado raised its position in shares of Trupanion by 12.9% during the second quarter. Public Employees Retirement Association of Colorado now owns 208,807 shares of the financial services provider’s stock worth $7,544,000 after purchasing an additional 23,807 shares during the period. Finally, Redmond Asset Management LLC acquired a new position in shares of Trupanion during the second quarter worth approximately $608,000. 95.04% of the stock is currently owned by hedge funds and other institutional investors.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Story: Understanding the two types of arbitrage
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.